Abbott Laboratories (BCBA:ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	274,560,794	316,199,857	202,265,940	154,491,179	33,906,310	24,785,975
Market Cap Growth	20.89%	56.33%	30.92%	355.64%	36.80%	57.12%
Enterprise Value	282,368,572	324,258,030	209,988,130	161,658,371	35,125,277	25,702,082
Last Close Price	41460.00	47549.71	33048.37	26042.89	9118.34	6865.91
PE Ratio	29.00	33.39	14.69	33.52	27.72	34.28
PS Ratio	4.27	4.92	4.68	4.76	4.39	5.60
PB Ratio	3.69	4.25	4.10	4.92	5.19	6.70
P/TBV Ratio	8.85	10.19	10.96	31.28	55.76	-
P/FCF Ratio	-	-	30.89	37.77	24.53	27.91
P/OCF Ratio	-	-	22.92	26.32	19.98	22.92
EV/Sales Ratio	4.53	5.04	4.86	4.99	4.54	5.81
EV/EBITDA Ratio	17.47	19.44	19.01	19.11	16.02	19.64
EV/EBIT Ratio	23.92	26.62	27.17	27.69	21.76	27.19
EV/FCF Ratio	-	-	32.07	39.52	25.41	28.94
Debt / Equity Ratio	0.25	0.25	0.32	0.41	0.49	0.53
Debt / EBITDA Ratio	1.13	1.13	1.38	1.48	1.41	1.47
Debt / FCF Ratio	-	-	2.41	3.16	2.30	2.23
Asset Turnover	-	-	0.54	0.54	0.58	0.58
Inventory Turnover	-	-	2.92	2.81	3.37	3.56
Quick Ratio	-	-	1.05	1.00	1.06	1.28
Current Ratio	-	-	1.67	1.64	1.63	1.85
Return on Equity (ROE)	13.16%	13.16%	30.91%	15.11%	19.01%	20.49%
Return on Assets (ROA)	-	-	6.06%	6.11%	7.61%	7.79%
Return on Invested Capital (ROIC)	11.45%	11.58%	14.59%	13.45%	16.96%	17.46%
Return on Capital Employed (ROCE)	-	-	11.10%	12.20%	15.50%	14.80%
Earnings Yield	3.45%	3.00%	6.83%	3.00%	3.62%	2.93%
FCF Yield	-	-	3.24%	2.65%	4.08%	3.58%
Dividend Yield	1.43%	7.33%	6.99%	6.46%	3.73%	2.72%
Payout Ratio	-	-	28.62%	62.13%	47.73%	45.28%
Buyback Yield / Dilution	-0.06%	-0.06%	0.06%	0.85%	1.40%	-0.17%
Total Shareholder Return	1.37%	7.27%	7.04%	7.31%	5.13%	2.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.